Evaluation of normal-sized ovaries associated with primary peritoneal serous carcinoma for possible precursors of ovarian serous carcinoma

Gynecologic Oncology

Volumn 106, Issue 1, 2007, Pages 201-206

  Seidman, Jeffrey D ^a   Wang, Brant G ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

BRCA genes; Carcinogenesis; Ovarian carcinoma; Peritoneal carcinoma; Risk factors; Serous carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYSTADENOCARCINOMA; FEMALE; HUMAN; INVAGINATION; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PAPILLOMATOSIS; PATIENT ASSESSMENT; PERITONEUM CANCER; PRIORITY JOURNAL;

AGED; CASE-CONTROL STUDIES; CYSTADENOCARCINOMA, SEROUS; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; OVARIECTOMY; OVARY; PERITONEAL NEOPLASMS; PRECANCEROUS CONDITIONS; RISK FACTORS;

EID: 34250169423     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.03.028     Document Type: Article

References (30)

1. Deligdish L., Gil J., Kerner H., Wu H.S., Beck D., and Gershoni-Baruch R. Ovarian dysplasia in prophylactic oophorectomy specimens: cytogenetic and morphometric correlations. Cancer 86 (1999) 1544-1560
2. Resta L., Russo S., Colucci G.A., and Prat J. Morphologic precursors of ovarian epithelial tumors. Obstet. Gynecol. 82 (1993) 181-186
3. Salazar H., Godwin A.K., Daly M.B., Laub P.B., Hogan M., Rosenblum N., et al. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies. J. Natl. Cancer Inst. 88 (1996) 1810-1820
4. Kaur T.B., Shen T., Gaughan J., Thompson J., Richardson M., Houck K.L., et al. Premalignant lesions in the contralateral ovary of women with unilateral ovarian carcinoma. Gynecol. Oncol. 93 (2004) 69-77
5. Kerner R., Sabo E., Gershoni-Baruch R., Beck D., and Ben-Izhak O. Expression of cell cycle regulatory proteins in ovaries prophylactically removed from Jewish Ashkenazi BRCA1 and BRCA2 mutation carriers: correlation with histopathology. Gynecol. Oncol. (2005) 367-375
6. Plaxe S.C., Deligdisch L., Dottino P.R., and Cohen C.J. Ovarian intraepithelial neoplasia in patients with stage I ovarian carcinoma. Gynecol. Oncol. 38 (1990) 367-372
7. Mittal K.R., Zeleniuch-Jacquotte A., Cooper J.L., and Demopoulos R.I. Contralateral ovary in unilateral ovarian carcinoma: a search for preneoplastic lesions. Int. J. Gynecol. Pathol. 12 (1993) 59-63
8. Werness B.A., Afify A.M., Bielat K.L., Eltabbakh G.H., Piver M.S., and Paterson J.M. Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer. Hum. Pathol. 30 (1999) 151-157
9. Westhoff C., Murphy P., Heller D., and Halim A. Is ovarian cancer associated with an increased frequency of germinal inclusion cysts?. Am. J. Epidemiol. 138 (1993) 90-93
10. Sherman M.E., Lee J.S., Burks R.T., Struewing J.P., Kurman R.J., and Hartge P. Histopathologic features of ovaries at increased risk for carcinoma: a case-control analysis. Int. J. Gynecol. Pathol. 18 (1999) 151-157
11. Tressera F., Grases P.J., Labastida R., and Ubeda A. Histological features of the contralateral ovary in patients with unilateral ovarian cancer: a case-control study. Gynecol. Oncol. 71 (1998) 437-441
12. Schlosshauer P.W., Cohen C.J., Penault-Llorca F., Miranda C.R., Bignon Y.-J., Dauplat J., et al. Prophylactic oophorectomy: a morphologic and immunohistochemical study. Cancer 98 (2003) 2599-2606
13. Stratton J.F., Buckley C.H., Lowe D., and Ponder B.A.J. Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. J. Natl. Cancer Inst. 91 (1999) 626-628
14. Barakat R.R., Federici M.G., Saigo P.E., Robson M.E., Offit K., and Boyd J. Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes. Cancer 89 (2000) 383-390
15. Zheng J., Benedict W.F., Xu H.-J., Hu S.X., Kim T.M., Velicescu M., et al. Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas. J. Natl. Cancer Inst. 87 (1995) 1146-1153
16. Werness B.A., and Eltabbakh G.H. Familial ovarian cancer and early ovarian cancer: biologic, pathologic, and clinical features. Int. J. Gynecol. Pathol. 20 (2001) 48-63
17. Bloss J.D., Liao S.-Y., Buller R.E., Manetta A., Berman M.L., McMeekin S., et al. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol. Oncol. 50 (1993) 347-351
18. Seidman J.D., and Mehrotra A. Benign ovarian serous tumors: a re-evaluation and proposed reclassification of serous "cystadenomas" and "cystadenofibromas". Gynecol. Oncol. 96 (2005) 395-401
19. Matthews D.E., and Farewell V.T. Using and understanding medical statistics. 2nd revised edition (1988), Karger, New York 178
20. Shih I.-M., and Kurman R.J. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am. J. Pathol. 164 (2004) 1511-1518
21. Singer G., Kurman R.J., Chang H.-W., Cho S.K.R., and Shih I.-M. Diverse tumorigenic pathways in ovarian serous carcinoma. Am. J. Pathol. 160 (2002) 1223-1228
22. Bell D.A., and Scully R.E. Ovary. In: Henson D.E., and Albores-Saavedra J. (Eds). Pathology of incipient neoplasia. 3rd edn. (2001), Oxford University Press, New York 419-440
23. Scully R.E. Early de novo ovarian cancer and cancer developing in benign ovarian lesions. Int. J. Gynecol. Obstet., Suppl. 49 (1995) S9-S15
24. Bell D.A., and Scully R.E. Early de novo ovarian carcinoma: a study of 14 cases. Cancer 73 (1994) 1859-1864
25. Feeley K.M., and Wells M. Precursor lesions of ovarian epithelial malignancy. Histopathology 38 (2001) 87-95
26. Roland I.H., Yang W.-L., Yang D.-H., et al. Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies. Cancer 98 (2003) 2607-2623
27. Cai K.Q., Klein-Szanto A., Karthik D., Edelson M., Daly M.B., Ozols R.F., et al. Age-dependent morphological alterations of human ovaries from populations with and without BRCA mutations. Gynecol. Oncol. 103 (2006) 719-728
28. Heller D.S., Murphy P., and Westhoff C. Are germinal inclusion cysts markers of ovulation?. Gynecol. Oncol. 96 (2005) 496-499
29. Blaustein A. Surface (germinal) epithelium and related ovarian neoplasms. Pathol. Annu. (1981) 247-294
30. Clement P.B. Ovary. In: Sternberg S.S. (Ed). Histology for pathologists. 1st edn. (1992), Raven Press, New York 765-795